Works matching IS 14397595 AND DT 2014 AND VI 24 AND IP 5


Results: 30
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study.

    Published in:
    Modern Rheumatology, 2014, v. 24, n. 5, p. 734, doi. 10.3109/14397595.2014.881709
    By:
    • Tanaka, Yoshiya;
    • Yamamoto, Kazuhiko;
    • Takeuchi, Tsutomu;
    • Yamanaka, Hisashi;
    • Ishiguro, Naoki;
    • Eguchi, Katsumi;
    • Watanabe, Akira;
    • Origasa, Hideki;
    • Shoji, Toshiharu;
    • Miyasaka, Nobuyuki;
    • Koike, Takao
    Publication type:
    Article
    19
    20

    Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.

    Published in:
    Modern Rheumatology, 2014, v. 24, n. 5, p. 715, doi. 10.3109/14397595.2013.864224
    By:
    • Yamamoto, Kazuhiko;
    • Takeuchi, Tsutomu;
    • Yamanaka, Hisashi;
    • Ishiguro, Naoki;
    • Tanaka, Yoshiya;
    • Eguchi, Katsumi;
    • Watanabe, Akira;
    • Origasa, Hideki;
    • Shoji, Toshiharu;
    • Sakamaki, Yoshiharu;
    • van der Heijde, Désirée;
    • Miyasaka, Nobuyuki;
    • Koike, Takao
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30